127 related articles for article (PubMed ID: 2983736)
1. Can ribonucleotide reductase be considered as an effective target for developing antiherpes simplex virus type II (HSV-2) compounds?
Nutter LM; Grill SP; Cheng YC
Biochem Pharmacol; 1985 Mar; 34(6):777-80. PubMed ID: 2983736
[TBL] [Abstract][Full Text] [Related]
2. Role of viral ribonucleotide reductase in the increase of dTTP pool size in herpes simplex virus-infected Vero cells.
Daikoku T; Yamamoto N; Maeno K; Nishiyama Y
J Gen Virol; 1991 Jun; 72 ( Pt 6)():1441-4. PubMed ID: 1646284
[TBL] [Abstract][Full Text] [Related]
3. The sources of thymidine nucleotides for virus DNA synthesis in herpes simplex virus type 2-infected cells.
Nutter LM; Grill SP; Cheng YC
J Biol Chem; 1985 Oct; 260(24):13272-5. PubMed ID: 2997161
[TBL] [Abstract][Full Text] [Related]
4. Antiherpes virus activity and effect on deoxyribonucleoside triphosphate pools of (E)-5-(2-bromovinyl)-2'-deoxycytidine in combination with deaminase inhibitors.
Aduma PJ; Gupta SV; De Clercq E
Antiviral Res; 1990 Mar; 13(3):111-25. PubMed ID: 2162147
[TBL] [Abstract][Full Text] [Related]
5. Deoxyribonucleoside triphosphate pools in synchronized human cells infected with herpes simplex virus types 1 and 2.
Roller B; Cohen GH
J Virol; 1976 Apr; 18(1):58-64. PubMed ID: 176471
[TBL] [Abstract][Full Text] [Related]
6. Viral ribonucleotide reductase attenuates the anti-herpes activity of acyclovir in contrast to amenamevir.
Shiraki K; Tan L; Daikoku T; Takemoto M; Sato N; Yoshida Y
Antiviral Res; 2020 Aug; 180():104829. PubMed ID: 32569704
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of herpes simplex virus ribonucleoside diphosphate reductase by derivatives of 2-acetylpyridine thiosemicarbazone.
Turk SR; Shipman C; Drach JC
Biochem Pharmacol; 1986 May; 35(9):1539-45. PubMed ID: 3011019
[TBL] [Abstract][Full Text] [Related]
8. Ribonucleotide reductase induced by herpes simplex type 1 virus. Characterization of a distinct enzyme.
Averett DR; Lubbers C; Elion GB; Spector T
J Biol Chem; 1983 Aug; 258(16):9831-8. PubMed ID: 6309786
[TBL] [Abstract][Full Text] [Related]
9. Deoxyribonucleoside triphosphate pools of herpes simplex virus infected cells: the influence of selective antiherpes agents and the role of the deaminase pathway.
Aduma PJ; Gupta SV; Stuart AL; Tourigny G
Biochem Cell Biol; 1991; 69(5-6):409-14. PubMed ID: 1654943
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyurea induces bystander cytotoxicity in cocultures of herpes simplex virus thymidine kinase-expressing and nonexpressing HeLa cells incubated with ganciclovir.
Gentry BG; Boucher PD; Shewach DS
Cancer Res; 2006 Apr; 66(7):3845-51. PubMed ID: 16585212
[TBL] [Abstract][Full Text] [Related]
11. Modulation of deoxynucleotide metabolism by the deoxycytidylate deaminase inhibitor 3,4,5,6-tetrahydrodeoxyuridine.
Heinemann V; Plunkett W
Biochem Pharmacol; 1989 Nov; 38(22):4115-21. PubMed ID: 2688654
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of nucleoside analog triphosphates on ribonucleotide reductases from uninfected and herpes simplex virus-infected HeLa cells.
Nakayama K; Ruth JL; Cheng YC
J Virol; 1982 Jul; 43(1):325-7. PubMed ID: 6287006
[TBL] [Abstract][Full Text] [Related]
13. 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovir.
Spector T; Harrington JA; Morrison RW; Lambe CU; Nelson DJ; Averett DR; Biron K; Furman PA
Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1051-5. PubMed ID: 2536930
[TBL] [Abstract][Full Text] [Related]
14. Tetrahydrouridine specifically facilitates deoxycytidine incorporation into herpes simplex virus DNA.
North TW; Mathews CK
J Virol; 1981 Mar; 37(3):987-93. PubMed ID: 6262539
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of a herpes simplex virus ribonucleotide reductase null mutant to deoxyribonucleosides and antiviral nucleoside analogs.
Yamada Y; Yamamoto N; Daikoku T; Nishiyama Y
Microbiol Immunol; 1991; 35(8):681-6. PubMed ID: 1661366
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ribonucleotide reductases encoded by herpes simplex viruses.
Spector T
Pharmacol Ther; 1985; 31(3):295-302. PubMed ID: 3035588
[No Abstract] [Full Text] [Related]
17. Synergistic enhancement of herpes simplex virus thymidine kinase/ganciclovir-mediated cytoxicity by hydroxyurea.
Boucher PD; Ostruszka LJ; Shewach DS
Cancer Res; 2000 Mar; 60(6):1631-6. PubMed ID: 10749133
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of viral thymidine kinase inhibitor and its effect on deoxynucleotide metabolism in cells infected with herpes simplex virus.
Nutter LM; Grill SP; Dutschman GE; Sharma RA; Bobek M; Cheng YC
Antimicrob Agents Chemother; 1987 Mar; 31(3):368-74. PubMed ID: 3034143
[TBL] [Abstract][Full Text] [Related]
19. Ribonucleotide reductase: an important enzyme in the replication of herpes simplex virus type 1 and a target for antiviral chemotherapy.
Prichard MN; Shipman C
Chemotherapy; 1995; 41(5):384-95. PubMed ID: 8521741
[TBL] [Abstract][Full Text] [Related]
20. Changes of deoxyribonucleoside triphosphate pools induced by hydroxyurea and their relation to DNA synthesis.
Bianchi V; Pontis E; Reichard P
J Biol Chem; 1986 Dec; 261(34):16037-42. PubMed ID: 3536919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
